BackAnthera Pharmaceuticals Overview

Anthera Pharmaceuticals Cost of Revenue

Cost of Revenue analysis for ANTH.

Quarterly Cost of Revenue

$7468.00
↓ 3.03% YoY

As of Mar 31, 2018

Annual Cost of Revenue (TTM)

$28261.00
↓ 36.25% YoY

Trailing 12 months ending Mar 31, 2018

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin